Friday, July 29, 2022

DeciBio Ventures Backs Replay In $55M Funding

Los Angeles-based venture investor DeciBio Ventures ays it has made an investment in genomic medicine technology company Replay. According to the company, Replay raised $55M in a seed funding round, which was led by KKR & Co. Inc. and OMX Ventures, and also included ARTIS Ventures, Lansdowne Partners, SALT, and Axial. DeciBio Ventures did not say how much it contributed to the funding. Replay is based in San Diego and London. DeciBio Ventures says it invests in precision medicine startups.